Thermo Fisher Scientific Inc header image

Thermo Fisher Scientific Inc

TMO

Equity

ISIN US8835561023 / Valor 977576

New York Stock Exchange, Inc (2024-09-17)
USD 610.49-0.60%

Thermo Fisher Scientific Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Thermo Fisher Scientific Inc. is a global leader in providing innovative technologies, purchasing convenience, and pharmaceutical services to enable customers to make the world healthier, cleaner, and safer. With annual revenue exceeding $40 billion, the company's diverse portfolio includes brands such as Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher serves a wide range of industries, from life sciences research to diagnostics and therapies, offering solutions to complex analytical challenges and increasing productivity in laboratories worldwide. With a team of over 90,000 colleagues, Thermo Fisher Scientific is dedicated to supporting its customers in their mission to drive scientific advancements and improve global health outcomes.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (07.08.2024):

Revenue Growth

Thermo Fisher Scientific Inc. reported total revenues of $10.54 billion for the second quarter of 2024. This represents a slight decrease compared to the $10.69 billion reported in the same quarter of the previous year. The revenue was driven by both product and service sales, with product revenues contributing $6.16 billion and service revenues contributing $4.38 billion.

Net Income

For the second quarter of 2024, Thermo Fisher Scientific Inc. achieved a net income of $1.55 billion. This is an increase from the $1.36 billion net income reported in the second quarter of 2023. The increase in net income reflects the company's effective cost management and operational efficiencies.

Earnings Per Share

Thermo Fisher Scientific Inc. reported earnings per share (EPS) of $4.05 for the second quarter of 2024. This is a slight increase from the EPS of $3.53 reported in the same quarter of the previous year. The diluted EPS for the quarter was $4.04, compared to $3.51 in the second quarter of 2023.

Operating Income

In the second quarter of 2024, Thermo Fisher Scientific Inc. reported an operating income of $1.82 billion. This is a decrease from the $1.58 billion reported in the second quarter of 2023. The operating income was impacted by higher costs and operating expenses, which totaled $8.72 billion for the quarter.

Cash Flow

Thermo Fisher Scientific Inc. generated $3.21 billion in net cash from operating activities during the first six months of 2024. This is an increase from the $2.27 billion generated in the same period of the previous year. The company ended the second quarter with $7.10 billion in cash and cash equivalents, compared to $8.10 billion at the beginning of the year.

Summarized from source with an LLMView Source

Key figures

18.4%1Y
2.29%3Y
109%5Y

Performance

21.4%1Y
25.8%3Y
28.2%5Y

Volatility

Market cap

239038 M

Market cap (USD)

Daily traded volume (Shares)

453,267

Daily traded volume (Shares)

1 day high/low

616 / 607

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

monday.com Ltd.
monday.com Ltd. monday.com Ltd. Valor: 111719549
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.60%USD 258.93
KK QPS Kenkyusho
KK QPS Kenkyusho KK QPS Kenkyusho Valor: 130606762
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.23%JPY 1,206.00
KK KOKUSAI ELECTRIC
KK KOKUSAI ELECTRIC KK KOKUSAI ELECTRIC Valor: 129802396
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.72%JPY 3,105.00
Editas Medicine Inc
Editas Medicine Inc Editas Medicine Inc Valor: 30992799
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.78%USD 3.86
NCR Voyix Corporation
NCR Voyix Corporation NCR Voyix Corporation Valor: 560034
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.20%USD 13.89
JinkoSolar Holding Co Ltd
JinkoSolar Holding Co Ltd JinkoSolar Holding Co Ltd Valor: 11035900
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.81%USD 20.12
Biotest AG
Biotest AG Biotest AG Valor: 325670
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 27.20
KK Obic Business Consultant
KK Obic Business Consultant KK Obic Business Consultant Valor: 902392
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.40%JPY 7,394.00
Relay Therapeutics Inc
Relay Therapeutics Inc Relay Therapeutics Inc Valor: 55675918
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-6.29%USD 7.60
Crayon Group Holding ASA
Crayon Group Holding ASA Crayon Group Holding ASA Valor: 38843127
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.92%NOK 130.50